EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Beshom Holdings Bhd (7668) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of Beshom Holdings Bhd MYR 0.61, price MYR 0.53, upside +16.2%, quality 63 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? Yes
  3. Add to watchlist

Healthcare · MY · ISIN MYL7668OO006

BH Thin data Sep 24, 2026

Beshom Holdings Bhd

7668 · KLSE

UndervaluedThe stock appears undervalued with acceptable quality.

✓Fair value 0.6100 MYR · Undervalued (+16%)
!Quality 63/100
!Weak Growth (revenue 5y −11.8 %/yr)
!Thin margins · 5.4% net margin (TTM)
✓Low debt · generates free cash flow
·4.76% dividend yield
✓Ranks above peers (11/14)
!Narrow moat 35/100
!Evidence only low, so the estimate is less certain
!Weak on past: 9 out of 100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

1.76 MYR 0.5100 MYR Fair Value 0.6100 MYR Apr 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range 0.5100 MYR – 1.76 MYR · fair‑value band 0.4500 MYR – 0.6900 MYR · the 0.5250 MYR price screens below the 0.6100 MYR fair value. Dashed = 300-day average. As of Sep 24, 2026.

Follow Beshom Holdings Bhd in your weekly email

Every Wednesday you see whether Beshom Holdings Bhd is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Beshom Holdings Berhad, an investment holding company, engages in the wholesale and retail of herbal medicines and healthcare products in Malaysia. The company provides wholesaling and trading in patented medicines, medicated tonic, cooking wine, healthcare products, wellness, herbs, and tea.

Show more

Beshom Holdings Berhad, an investment holding company, engages in the wholesale and retail of herbal medicines and healthcare products in Malaysia. The company provides wholesaling and trading in patented medicines, medicated tonic, cooking wine, healthcare products, wellness, herbs, and tea. It also offers multi-level direct marketing of nutritional food and beverage, wellness supplements, skincare, beauty and cosmetic, personal care and household products. In addition, it provides operating traditional complementary medicines (TCM) retail chain stores and physician consultation services. Further, it engages in manufacturing of TCM supplements; credit and leasing; insurance agency; and investment holding and property holding. The company operates retail chain stores and franchises; and multi-level-marketing branches, stockists, and sales points. The company was founded in 1975 and is headquartered in Petaling Jaya, Malaysia.

Stock analysis

Beshom Holdings Bhd (7668) currently trades at 0.5250 MYR, while our model-based Fair Value estimate is 0.6100 MYR, implying the stock looks roughly 13.9% undervalued today.

Show more

Valuation

Bull case: the Asset-Based group reads highest at a median of 0.6800 MYR per share, and 16 of the 22 models we run sit above the 0.5250 MYR price.

Bear case: the Earnings-Based group reads lowest at 0.2200 MYR, and 6 of the 22 models stay below the price. Evidence for this calculation is low.

Scenario range: 0.4500 MYR (bear) to 0.6900 MYR (bull), the price of 0.5250 MYR sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 63/100 (solid quality), in the Healthcare sector.

Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.

Beshom Holdings Bhd reported revenue of 145M MYR in FY2026 versus 210M MYR in FY2022, a compound −8.8%/yr. Reported net income was 7.9M MYR in FY2026, compounding −27.4%/yr from FY2022.

Key figures

Market cap 157M MYR (≈ $38.5M) · P/E ratio 17.5 · P/S ratio 0.95 · EPS (TTM) 0.0300 MYR · Dividend yield 4.8% · Net margin 5.4% · Return on equity 2.4% · Return on assets (EBIT) 5.6%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 46 out of 100 (low confidence).

What moves the price

The share trades about 23% below its 52-week high and 3% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 10% fair-value upside, at 16%, 7668 screens cheaper than that median.

Fair Value models

Bear 0.4500 MYR Fair Value 0.6100 MYR Bull 0.6900 MYR
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2026 figures (about 5 months old). Earnings retained since then (0.0020 MYR per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF 0.4800 MYR 0.6300 MYR 0.9100 MYR 81
Growth DCF 0.5000 MYR 0.6500 MYR 0.8900 MYR 79
Owner Earnings 0.4300 MYR 0.5600 MYR 0.8000 MYR 77
All 22 models by family
DCF Models
FCF DCF 0.4800 MYR 0.6300 MYR 0.9100 MYR 81
Owner Earnings 0.4300 MYR 0.5600 MYR 0.8000 MYR 77
5Y Revenue Exit 0.4100 MYR 0.5500 MYR 0.7600 MYR 73
5Y EBITDA Exit 0.5000 MYR 0.7100 MYR 0.9800 MYR 76
5Y P/E Exit 0.4400 MYR 0.6100 MYR 0.8100 MYR 71
10Y Revenue Exit 0.4300 MYR 0.5400 MYR 0.6500 MYR 68
10Y EBITDA Exit 0.4900 MYR 0.6300 MYR 0.7700 MYR 70
10Y P/E Exit 0.4600 MYR 0.5700 MYR 0.6800 MYR 65
Earnings-Based
Graham-Dodd 0.1800 MYR 0.2200 MYR 0.2500 MYR 67
EPV 0.2300 MYR 0.2500 MYR 0.2800 MYR 74
Multiples
P/E Multiple 0.4100 MYR 0.5500 MYR 0.6900 MYR 63
P/S Multiple 0.3300 MYR 0.4500 MYR 0.5600 MYR 58
P/B Multiple 0.3300 MYR 0.4500 MYR 0.5600 MYR 55
EV/EBIT 0.5200 MYR 0.6700 MYR 0.8300 MYR 66
EV/EBITDA 0.5900 MYR 0.7600 MYR 0.9300 MYR 67
EV/Revenue 0.3900 MYR 0.5300 MYR 0.6700 MYR 54
Asset-Based
NCAV (Graham) 0.5100 MYR 0.6800 MYR 1.02 MYR 54
Growth DCF
Growth DCF 0.5000 MYR 0.6500 MYR 0.8900 MYR 79
Rev-Margin DCF 0.4100 MYR 0.5600 MYR 0.7500 MYR 73
Economic Profit
Residual Income 0.7200 MYR 0.6900 MYR 0.5500 MYR 76
ROIC Compounder 0.2300 MYR 0.2500 MYR 0.2800 MYR 72
Growth Earnings
Growth-Adj P/E 0.2900 MYR 0.4200 MYR 0.5400 MYR 67

Open the full fair value analysis →

Notify me when 7668 reaches fair value

Put 7668 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 63/100

Of which business quality 63 · Market factors (momentum, volatility) 41

Profitability 27
Margins and returns on capital today
Quality Growth 28
Are margins and returns improving?
Cashflow 68
Earnings quality: real cash, not paper profit
Fin. Strength 84
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 86
Calm price path (market factor)
Momentum 28
Price trend over the last 3–12 months (market factor)
52W Momentum 11
Distance to the 52-week high (market factor)
Net Issuance 83
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−6.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−6.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−11.8%
Start year 2021 (pandemic). Over 10 years: −7.0% a year
Revenue growth 13 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−4.6%
What shareholders gained per year (last 5 years), in MYR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in MYR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−19.8%
Earnings growth per share plus dividend.
Earnings per share, growth per year−24.6%
Dividend (yield on the price)4.8%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−25% vs −18%, slowing
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.19% → 7%
Start year 2021 (pandemic)
⚠ Revenue per share shrinking 13.1%/yr over ~7Y (margins eroding too) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.

Growth Forecast

Price in line with expectations
The price assumes about as much growth as the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−14.5%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Malaysia: IMF forecast 2.0% a year to 2030, 1.8% from 2016 to 2025) that is about −16.2% a year for the price.

Watch 7668, get fair value alerts →

Compare Beshom Holdings Bhd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Pharmaceutical Retailers · 61 stocks

Beats the industry median on 11/14 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 63 · Top 25%
Fair Value upside +16% · Above median
Profitability
Return on equity (TTM) 2% · Below median
Return on assets 2% · Above median
Net margin (TTM) 5% · Top 25%
Operating margin (TTM) 8% · Top 25%
Growth and dividend
Revenue growth −2% · Below median
Dividend yield (TTM) 4.8% · Above median
Balance sheet
Debt / equity 0.01× · Below median

Valuation Multiplesvs Pharmaceutical Retailers median · lower = cheaper

P/E (TTM) 17.5× · Cheaper than median
P/B 0.13× · Cheapest 25%
P/S (TTM) 0.27× · Cheaper than median
P/FCF 2.9× · Priciest 25%
EV/EBITDA 1.3× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)55 · sector 33
FUTURE (revenue growth)0 · sector 19
PAST (return on equity)9 · sector 22
HEALTH (low debt)100 · sector 96
DIVIDEND (yield)95 · sector 64

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Pharmaceutical Retailers stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Alibaba Health Information Technology Limited 0241 HK$2.84 HK$2.03 −28%
Yifeng Pharmacy Chain Co 603939 ¥22.09 ¥40.59 +84%
DaShenLin Pharmaceutical Group 603233 ¥17.97 ¥26.45 +47%
LBX Pharmacy Chain Joint Stock Company 603883 ¥12.90 ¥14.19 +10%
MedPlus Health Services Limited MEDPLUS ₹662.00 ₹393.38 −41%
Yixintang Pharmaceutical Group 002727 ¥10.96 ¥9.51 −13%
Anhui Huaren Health Pharmaceutical Co 301408 ¥15.56 ¥17.12 +10%
ShuYu Civilian Pharmacy Corp 301017 ¥12.95 ¥5.91 −54%
Apotea AB APOTEA kr 81.90 kr 46.46 −43%
Luyan Pharma Co 002788 ¥11.24 ¥15.91 +42%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Beshom Holdings Bhd Fair Value". https://www.fairvalue-calculator.com/stock/7668

Frequently asked questions

Is Beshom Holdings Bhd (7668) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 0.6100 MYR versus a price of 0.5250 MYR, about +16% upside (undervalued).
What is the fair value of 7668?
Our model-based fair value for Beshom Holdings Bhd is 0.6100 MYR (as of Sep 24, 2026), built from audited fundamentals. The current price: 0.5250 MYR.
What is the quality score of 7668?
Beshom Holdings Bhd has a Quality Score of 63/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Beshom Holdings Bhd (7668)?
Our model-based price target is the fair value of 0.6100 MYR (as of Sep 24, 2026) from 22 valuation models. Cautious scenario 0.4500 MYR, optimistic scenario 0.6900 MYR. It is a calculation from audited fundamentals, not an analyst target.
What is the Beshom Holdings Bhd stock forecast for 2026?
Our models put fair value at 0.6100 MYR, about +16% upside versus a price of 0.5250 MYR (undervalued). Cautious scenario 0.4500 MYR, optimistic scenario 0.6900 MYR. The calculation is refreshed regularly with new filings.
What is the revenue of Beshom Holdings Bhd (7668)?
Beshom Holdings Bhd reported trailing-twelve-month revenue of about 145M MYR (latest available figure, as of Sep 24, 2026).
Does Beshom Holdings Bhd pay a dividend?
Beshom Holdings Bhd currently shows a dividend yield of about 4.76% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Beshom Holdings Bhd (7668)?
For today's price to be fair in a discounted-cash-flow model, Beshom Holdings Bhd would have to grow free cash flow by -14.5 % per year for five years (discount rate 9.7 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew -11.8 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 7668 use?
Our models discount Beshom Holdings Bhd at 9.7 %: a base by market capitalisation (nano), damped by beta 0.16, country premium for Malaysia. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Beshom Holdings Bhd that is -14.5 % per year a year over ten years, using the same discount rate (9.7 %) and the same formula as our fair value.
How much growth has Beshom Holdings Bhd (7668) delivered so far?
Over the past 5 years revenue at Beshom Holdings Bhd grew -11.8 % a year. The price currently implies -14.5 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Beshom Holdings Bhd (7668) growing?
The median revenue growth in the sector is +2.8 % a year. That is the yardstick for the growth priced into Beshom Holdings Bhd (-14.5 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Beshom Holdings Bhd (7668)?
The free-cash-flow yield on the price is 8.32 %: that much free cash flow Beshom Holdings Bhd produces per unit of market value. When it exceeds the discount rate of our models (9.7 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Beshom Holdings Bhd (7668)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Beshom Holdings Bhd it is 0.6100 MYR per share (as of Sep 24, 2026), against a price of 0.5250 MYR. It is the blended result of 22 valuation models (cash flow, earnings, asset, dividend).
Is Beshom Holdings Bhd stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 7668 trades below its calculated fair value: price 0.5250 MYR, fair value 0.6100 MYR, a gap of about +16% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 7668?
No. The price is what the market pays today (0.5250 MYR); the fair value is what the company's own numbers justify (0.6100 MYR). For Beshom Holdings Bhd the two are 0.0850 MYR per share apart. That gap is exactly why we show both numbers side by side.
How much is Beshom Holdings Bhd worth?
The market values Beshom Holdings Bhd at about 157M MYR (market capitalisation, as of Sep 24, 2026). Per share that is 0.5250 MYR; our models calculate a fair value of 0.6100 MYR per share.
What do the bullish and bearish scenarios say about 7668?
Our models span a range for Beshom Holdings Bhd: cautious scenario 0.4500 MYR, base 0.6100 MYR, optimistic 0.6900 MYR per share (as of Sep 24, 2026, price 0.5250 MYR). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 7668?
Beshom Holdings Bhd trades at a price-to-earnings ratio of 17.5 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 0.6100 MYR is built from several models across several years. Other multiples: P/B 0.1, P/S 0.3, EV/EBITDA 1.3.
How solid is the balance sheet of Beshom Holdings Bhd (7668)?
Balance-sheet figures for Beshom Holdings Bhd (as of Sep 24, 2026): return on equity 2.4%, debt of 0.01 per unit of equity. They feed the Quality Score of 63/100, which measures business quality independently of the share price.
How far is 7668 from its 52-week high?
Beshom Holdings Bhd trades at 0.5250 MYR, about 23% below its 52-week high of 0.6784 MYR and 3% above the low of 0.5100 MYR (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 0.6100 MYR is for.
Which stocks are comparable to Beshom Holdings Bhd?
From the same area (Healthcare) we also value Alibaba Health Information Technology Limited, Yifeng Pharmacy Chain Co, DaShenLin Pharmaceutical Group, LBX Pharmacy Chain Joint Stock Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Beshom Holdings Bhd stock attractive at the current price?
The data as of Sep 24, 2026: price 0.5250 MYR, calculated fair value 0.6100 MYR (+16%), Quality Score 63/100, from 22 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 7668 calculated?
We run Beshom Holdings Bhd through 22 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 0.6100 MYR, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Beshom Holdings Bhd currently trades 16 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Beshom Holdings Bhd (7668)?
The closing price on Sep 23, 2026 was 0.5250 MYR. Our model-based fair value is 0.6100 MYR, about +16% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Beshom Holdings Bhd right now?
Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual. The price sits in the lower half of our model range, the side with the larger margin of safety. Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.

Key figures of Beshom Holdings Bhd

How large is the market capitalisation of Beshom Holdings Bhd (7668)?
The market capitalisation of Beshom Holdings Bhd is 157M MYR (≈ $38.5M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Beshom Holdings Bhd (7668)?
The price-to-sales ratio of Beshom Holdings Bhd is 0.95 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Beshom Holdings Bhd (7668)?
Earnings per share at Beshom Holdings Bhd are 0.0300 MYR (price ÷ EPS = P/E 17.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Beshom Holdings Bhd (7668)?
The dividend yield of Beshom Holdings Bhd is 4.8% (payout 83.3%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Beshom Holdings Bhd (7668)?
The net margin of Beshom Holdings Bhd is 5.4% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Beshom Holdings Bhd (7668)?
The return on equity (ROE) of Beshom Holdings Bhd is 2.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Beshom Holdings Bhd (7668)?
On an EBIT basis the return on assets of Beshom Holdings Bhd is 5.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Beshom Holdings Bhd (7668)?
The operating margin of Beshom Holdings Bhd is 8.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Beshom Holdings Bhd (7668)?
Revenue at Beshom Holdings Bhd is growing −1.6% versus a year earlier (3y avg −6.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Beshom Holdings Bhd (7668)?
Earnings per share at Beshom Holdings Bhd are growing +4.5% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed

Watch Beshom Holdings Bhd in the live analysis

One click puts Beshom Holdings Bhd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.